HighTower Advisors, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 64 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$2,738,000
-31.6%
5,284,6880.0%0.01%
-40.9%
Q2 2020$4,000,000
-25.8%
5,284,6880.0%0.02%
-37.1%
Q1 2020$5,390,000
-34.2%
5,284,688
+0.0%
0.04%
-27.1%
Q4 2019$8,192,000
-14.4%
5,284,613
-0.0%
0.05%
-7.7%
Q3 2019$9,565,000
+10.4%
5,284,7380.0%0.05%0.0%
Q2 2019$8,667,000
-8.4%
5,284,738
-0.0%
0.05%
-17.5%
Q1 2019$9,460,000
-4.8%
5,284,838
+0.5%
0.06%
-17.1%
Q4 2018$9,942,000
+6.9%
5,260,088
+101.9%
0.08%
+13.4%
Q3 2018$9,303,000
+65.3%
2,605,644
-3.7%
0.07%
+52.3%
Q2 2018$5,628,0002,705,6440.04%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders